Literature DB >> 6611185

Modulation of EL-4 mouse lymphoma cell proliferation by macrophages and tumor related factors.

A Pessina, P Brambilla, P Mocarelli.   

Abstract

It is well known that macrophages play an important role in the control of tumor growth. This control may be the result of a direct action of macrophages or mediated by several biologically active products or factors elaborated by these and other cell populations. Our studies on the proliferation of a murine T-cell lymphoma (EL-4) showed that the treatment of the ascitic fluid (from the peritoneum of EL-4 bearing mice) with carbonyl iron resulted in a depletion of phagocytes concomitant with a significant increase of [3H] thymidine uptake by EL-4 cells. Further, the growth of EL-4 cells cultured in semisolid agar was significantly inhibited by an underlayer of large quantities of macrophages both from normal and EL-4 bearing mice as well as when cultured in the presence of PGE2. The underlayer of tumor macrophages P388 D1 resulted in an increase of the EL-4 cell growth. Also, conditioned media obtained from in vitro liquid cultures of EL-4 cells and L 1210 cells (B-lymphoma) produced a remarkable inhibition of the in vitro cloning capacity and [3H] thymidine uptake by EL-4 cells. These data support the hypothesis that different factors from normal and hemopoietic tumor cells may control the tumor growth and point out that self-produced factors may modulate the proliferation of tumor cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6611185     DOI: 10.1007/bf00320383

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  14 in total

1.  Identification of macrophage-like characteristics in a cultured murine tumor line.

Authors:  H S Koren; B S Handwerger; J R Wunderlich
Journal:  J Immunol       Date:  1975-02       Impact factor: 5.422

2.  Two biological activities regulating cell proliferation found in cultures of peritoneal exudate cells.

Authors:  J Calderon; E R Unanue
Journal:  Nature       Date:  1975-01-31       Impact factor: 49.962

3.  Observations on the effect of a folic-acid antagonist on transplantable lymphoid leukemias in mice.

Authors:  L W LAW; T B DUNN
Journal:  J Natl Cancer Inst       Date:  1949-08       Impact factor: 13.506

4.  Macrophages in syngeneic animal tumours.

Authors:  R Evans
Journal:  Transplantation       Date:  1972-10       Impact factor: 4.939

5.  Cooperation of immune lymphoid cells with macrophages in tumour immunity.

Authors:  R Evans; P Alexander
Journal:  Nature       Date:  1970-11-14       Impact factor: 49.962

6.  Inhibition of Ehrlich ascites carcinoma (EAC) growth by carbonyl iron.

Authors:  A Pessina; P Brambilla; D Balzarin
Journal:  Experientia       Date:  1978-11-15

7.  Effect of tumor-related factors on the in vivo and in vitro colony-forming ability of normal mouse marrow cells.

Authors:  A Pessina; S Eridani; P Brambilla; G Cattoretti; A Marocchi; P Mocarelli
Journal:  Neoplasma       Date:  1981       Impact factor: 2.575

8.  Factors produced by macrophages and tumor cells: influence on the granulocytic precursor cells (CFU-C) in normal and tumor-bearing mice.

Authors:  A Pessina; P Brambilla; S Villa; A Marocchi; P Mocarelli
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

9.  Rejection of ascites tumor allografts. I. Isolation, characterization, and in vitro reactivity of peritoneal lymphoid effector cells from BALB-c mice immune to EL4 leukosis.

Authors:  G Berke; K A Sullivan; B Amos
Journal:  J Exp Med       Date:  1972-06-01       Impact factor: 14.307

10.  Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages.

Authors:  J I Kurland; R Bockman
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

View more
  2 in total

1.  Establishment and characterization of a new murine cell line (SR-4987) derived from marrow stromal cells.

Authors:  A Pessina; E Mineo; M G Neri; L Gribaldo; R Colombi; P Brambilla; G Zaleskis
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

2.  Pro-Resolving Factor Administration Limits Cancer Progression by Enhancing Immune Response Against Cancer Cells.

Authors:  Audrey Wetzel; Francis Bonnefoy; Cécile Chagué; Mathieu Vetter; Mélanie Couturier; Blandine Baffert; Olivier Adotévi; Philippe Saas; Sylvain Perruche
Journal:  Front Immunol       Date:  2022-01-18       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.